You have a lot to protect, bank more than cord blood.

Quentin's Cure: A Little Boy Makes History

As a pediatric cancer transplant specialist, Dr. Lolie Yu is accustomed to treating very sick children - and to outcomes that are sometimes bleak. When the renowned pediatric oncologist met 4-year-old Quentin in 2007, she knew that the chance of survival was less than 30% for his particular type of cancer.

According to Dr. Yu, the likelihood of death from the boy's form of acute lymphoblastic leukemia was "very high". But there was one glimmer of hope: At the time Quentin was diagnosed, his mother was pregnant with a sibling. Dr. Yu suggested collecting both the cord blood and the placenta blood of the new baby at birth.

Quentin's parents agreed. After the baby was delivered, they banked the placenta blood and cord blood with LifebankUSA - and discovered that the stem cells were a perfect match for Quentin.

A short time later, Dr. Yu skillfully performed the firstever transplant using stem cells from both the placenta and the umbilical cord. And Quentin began healing shortly thereafter.

Celebrating the cure

Quentin's cancer has been in continuous, complete remission since his transplant surgery. He was deemed fully cured on March 28, 2010, which marked the 2-year anniversary of his transplant.*

The success of Quentin - a "cutie pie!" according to Dr. Yu - is extremely gratifying to her and her colleagues. In fact, she said she can't resist developing a close bond with the families of the children she treats. When she helps cure a child of a deadly disease, Dr. Yu said that she feels incredibly blessed to have had the opportunity to save a life.

*Individual results may vary. There is no guarantee of similar transplant success.

Recent press on Quentin's success story

Baby sister helps cure boy of leukemia
Experimental treatment aids children with leukemia
A mother's miracle

The future is filled with possibilities

Dr. Yu is looking ahead to the potential of regenerative medicine - and believes stem cells hold the key to the treatment of many different diseases.

"If someone asks me, 'Do you think I should collect and store the cord blood stem cells from my baby?' my answer at this point is, 'Yes, if you can afford to, then you should probably do it. Because we don't know what the future will hold.'"

Cord blood and placenta-derived stem cells banked with LifebankUSA are indicated for hematopoietic reconstitution (the reformation of blood cellular components) for autologous use or use in first or second degree blood relatives. Any use of cord blood and placental stem cells other than for hematopoietic reconstitution is considered investigational, including regenerative medicine* therapies.

The chance that a child will use his/her own stored stem cells during his/her lifetime for currently treated conditions is estimated at 1 in 400.† These odds may increase if there is a family history of certain blood disorders or cancers. The potential risks and benefits of stem cell transplantation vary and depend on many factors, such as the amount and quality of the stem cells collected, the HLA compatibility between recipient and donor, and the client's overall health. Talk with your health care provider. For more information, call us at 1-877-LIFEBANKUSA ( 1-877-543-3226 ).

*These uses are not consistent with current labeling, are investigational and may never become standard therapy.
† Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant. 2008;14(3):316-322.